Protective Effect of Vaccine Promoted Neutralizing Antibodies against the Intracellular Pathogen Chlamydia trachomatis.

about

Bacterial Vaccine Antigen Discovery in the Reverse Vaccinology 2.0 Era: Progress and Challenges

P2860

Q57817461-91A998C8-0A15-471C-A77E-742F7FD3EA34

P2860

Protective Effect of Vaccine Promoted Neutralizing Antibodies against the Intracellular Pathogen Chlamydia trachomatis.

Item

http://www.wikidata.org/entity/Q47194154

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Protective Effect of Vaccine P ...... athogen Chlamydia trachomatis.

@en

Protective Effect of Vaccine P ...... athogen Chlamydia trachomatis.

@nl

type

Item

label

Protective Effect of Vaccine P ...... athogen Chlamydia trachomatis.

@en

Protective Effect of Vaccine P ...... athogen Chlamydia trachomatis.

@nl

prefLabel

Protective Effect of Vaccine P ...... athogen Chlamydia trachomatis.

@en

Protective Effect of Vaccine P ...... athogen Chlamydia trachomatis.

@nl

P1476

Protective Effect of Vaccine P ...... athogen Chlamydia trachomatis.

@en

P2093

Anja Weinreich Olsen

http://www.w3.org/2001/XMLSchema#string

Emma Kathrine Lorenzen

http://www.w3.org/2001/XMLSchema#string

Frank Follmann

http://www.w3.org/2001/XMLSchema#string

Ida Rosenkrands

http://www.w3.org/2001/XMLSchema#string

P2860

Immunogenicity of a chimeric peptide corresponding to T helper and B cell epitopes of the Chlamydia trachomatis major outer membrane protein

Global Estimates of the Prevalence and Incidence of Four Curable Sexually Transmitted Infections in 2012 Based on Systematic Review and Global Reporting

Functional and structural mapping of Chlamydia trachomatis species-specific major outer membrane protein epitopes by use of neutralizing monoclonal antibodies

RAG-1-deficient mice have no mature B and T lymphocytes

A 3-dimensional trimeric β-barrel model for Chlamydia MOMP contains conserved and novel elements of Gram-negative bacterial porins

Transient antibody-mucin interactions produce a dynamic molecular shield against viral invasion

Simultaneous Subcutaneous and Intranasal Administration of a CAF01-Adjuvanted Chlamydia Vaccine Elicits Elevated IgA and Protective Th1/Th17 Responses in the Genital Tract.

Characterization of a neutralizing monoclonal antibody directed at the lipopolysaccharide of Chlamydia pneumoniae.

Immunity to murine Chlamydia trachomatis genital tract reinfection involves B cells and CD4(+) T cells but not CD8(+) T cells.

Protective role of serum antibody in immunity to chlamydial genital infection.

P304

1652

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3389/FIMMU.2017.01652

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Peter Andersen

P577

2017-12-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29312283

http://www.w3.org/2001/XMLSchema#string

P921

Chlamydia trachomatis

P932

5732375

http://www.w3.org/2001/XMLSchema#string

Protective Effect of Vaccine Promoted Neutralizing Antibodies against the Intracellular Pathogen Chlamydia trachomatis.

about

P2860

P2860

Protective Effect of Vaccine Promoted Neutralizing Antibodies against the Intracellular Pathogen Chlamydia trachomatis.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P50

P577

P698

P921

P932